Canopy Growth Corporation (WEED.TO) (CGC) collaborates with Parent Action on Drugs to launch digital cannabis education tools

“Now that cannabis is legalized in Canada , we have a tremendous responsibility to ensure families have the tools they need to have pragmatic, well-informed conversations about cannabis,” commented Hilary Black , Chief Advocacy Officer, Canopy Growth. “It is our privilege to have brought together Canadian Students for Sensible Drug Policy and Parent Action on Drugs, the leaders in evidence-based education for youth to develop these essential interactive tools we are launching today.”

Today’s announcement follows the recent publication by CSSDP of a comprehensive cannabis education toolkit aimed at youth as part of the first phase of the partnership with Canopy Growth, CSSDP and PAD. The Sensible Cannabis Education: A Toolkit for Educating Youth focuses on realistic and evidence-based approaches to cannabis education for young Canadians. Since its launch, it has been viewed online over 1,000 times, with over 500 hard copies in English and French being distributed to parents, educators, other stakeholders and youth.

Canopy Growth continues to focus on engaging in meaningful Corporate Social Responsibility (“CSR”) initiatives. Its CSR strategy is based on listening to communities and stakeholders and supporting areas where awareness and education can make a difference. Just some of the initiatives Canopy Growth has undertaken include:

• A $2.5 million donation to the University of British Columbia  to establish the Canopy Growth Professorship of Cannabis Science, held by Dr. M-J Milloy, who is examining the potential utility of cannabis in addressing the opioid crisis.
• A three-way partnership with the Canadian Drug Policy Coalition (CDPC) and Mothers Against Drunk Driving Canada (MADD Canada) to increase awareness and education surrounding the dangers of driving under the influence of cannabis.
• A two-year partnership with the Canadian AIDS Society, which has been working on issues related to medical cannabis access since 2004, to fund the development of Canadian guidelines on the use of medical cannabis for the management of chronic pain and associated symptoms.

Here’s to Future (Responsible) Growth.

About Parent Action on Drugs
Parent Action on Drugs is a Canadian registered charitable organization, has addressed the issues related to youth substance use since 1983. PAD develops and disseminates a range of programs and resources for parents, youth, educators, health promoters and communities. We aim to reduce the harms associated with the use of alcohol and other drugs and increase informed decision making and build resiliency among youth.

About Canadian Students for Sensible Drug Policy (CSSDP)
Canadian Students for Sensible Drug Policy (CSSDP is a grassroots national network comprised of youth and students who are concerned about the negative impact our drug policies have on individuals and communities. CSSDP considers problematic drug use in society primarily a health issue rather than a criminal justice issue, and advocates for appropriate, evidence based responses to reduce and prevent harm from drug use. CSSDP currently runs 12 local youth-run chapters across Canada , in addition to a national Board of Directors, and is working to increase access and awareness of harm reduction, support evidence-based legislation, and promote drug policy reform on local, national and international levels.

About Canopy Growth Corporation
Canopy Growth (TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through the Company’s subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. The Company has operations in over a dozen countries across five continents.

The Company’s medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics.

The Company operates retail stores across Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and loyal following by focusing on quality products and meaningful customer relationships.

From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icons Snoop Dogg and Seth Rogen , breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates ten licensed cannabis production sites with over 4.6 million square feet of production capacity, including over one million square feet of GMP certified production space. For more information visit www.canopygrowth.com

Notice Regarding Forward Looking Statements
This news release contains “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and “forward-looking information” within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Canopy Growth or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release. Examples of such statements include “launch two new digital tools, and “continues to focus on engaging in meaningful Corporate Social Responsibility (“CSR”) initiatives”. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including tool functionality, and such risks contained in the Company’s annual information form dated June 27, 2018 and filed with Canadian securities regulators available on the Company’s issuer profile on SEDAR at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information or forward-looking statements in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information and forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking information or forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities laws.